- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/54 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame
Patent holdings for IPC class A61K 31/54
Total number of patents in this class: 713
10-year publication summary
|
41
|
31
|
24
|
36
|
33
|
34
|
45
|
26
|
18
|
15
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3737 |
17 |
| Bristol-myers Squibb Company | 4747 |
11 |
| Imago Biosciences, Inc. | 39 |
10 |
| Merck Sharp & Dohme Corp. | 2183 |
9 |
| Geistlich Pharma AG | 137 |
9 |
| Scent Science International Inc. | 18 |
9 |
| Sanofi | 4316 |
9 |
| Boehringer Ingelheim International GmbH | 4487 |
8 |
| Shionogi & Co., Ltd. | 884 |
8 |
| Persevere Therapeutics Inc | 17 |
8 |
| Glaxosmithkline LLC | 527 |
7 |
| CorMedix Inc. | 58 |
7 |
| Rigel Pharmaceuticals, Inc. | 505 |
7 |
| Janssen Pharmaceutica N.V. | 3160 |
6 |
| The Hospital for Sick Children | 411 |
6 |
| Mcmaster University | 833 |
6 |
| Soleno Therapeutics, Inc. | 37 |
6 |
| Amgen Inc. | 4431 |
5 |
| Abbvie Inc. | 1823 |
5 |
| Children's Medical Center Corporation | 1959 |
5 |
| Other owners | 555 |